Source:http://linkedlifedata.com/resource/pubmed/id/18534651
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2008-7-15
|
pubmed:abstractText |
The purpose of this study was to investigate the role of the oestrogen receptor subtypes ERalpha and ERbeta in mediating the non-genomic effects of 17-beta-estradiol (E(2)) in two human endometrial cancer cell lines (RL95-2 and HEC-1A) expressing different levels of these receptor subtypes. Western blotting analysis using phosphorylation site-specific antibodies showed that physiological concentrations of E(2) rapidly (<20 min) activated PKCalpha, but not PKCdelta in the RL95-2 cell line. E(2) had no effect on PKCalpha or PKCdelta activity in the HEC-1A cell line and suppressed basal levels of PKA activity in both cell lines. PKCalpha activation coincided with its membrane translocation. ERalpha was detected in the RL95-2 cell line by Western blotting and RT-PCR but not in the HEC-1A cells, which did express ERbeta. A selective ERalpha agonist PPT had the same effect as E(2) on PKCalpha activation in the RL95-2 cells, but the selective ERbeta agonist DPN had no such effect. A 46kDa variant of ERalpha increased in abundance in the cell membrane within 20 min of E(2) treatment suggesting that ERalpha mediated the E(2) non-genomic effects on PKCalpha through the formation of a membrane associated signalling complex.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Indicators and Reagents,
http://linkedlifedata.com/resource/pubmed/chemical/PRKCA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazolium Salts
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0039-128X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1110-22
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18534651-Cell Line, Tumor,
pubmed-meshheading:18534651-Cell Membrane,
pubmed-meshheading:18534651-Cell Proliferation,
pubmed-meshheading:18534651-Endometrial Neoplasms,
pubmed-meshheading:18534651-Enzyme Activation,
pubmed-meshheading:18534651-Estradiol,
pubmed-meshheading:18534651-Estrogen Receptor alpha,
pubmed-meshheading:18534651-Female,
pubmed-meshheading:18534651-Humans,
pubmed-meshheading:18534651-Indicators and Reagents,
pubmed-meshheading:18534651-Phosphorylation,
pubmed-meshheading:18534651-Protein Kinase C-alpha,
pubmed-meshheading:18534651-Tetrazolium Salts,
pubmed-meshheading:18534651-Time Factors
|
pubmed:year |
2008
|
pubmed:articleTitle |
Membrane ERalpha-dependent activation of PKCalpha in endometrial cancer cells by estradiol.
|
pubmed:affiliation |
Shanghai First Maternity and Infant Health Hospital, Tongji University, 536 Chang-Le Road, Shanghai, PR China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|